A pre‑formulated research blend combining two widely studied synthetic peptides: BPC-157 (Body Protection Compound-157) and TB-500 (Thymosin Beta-4 Fragment). Each component has been individually characterized in peer‑reviewed literature for its distinct biochemical properties related to cellular repair, actin regulation, and tissue protection. This 20mg total mass blend (1:1 molar ratio) is supplied as a lyophilized (freeze‑dried) powder in a single glass vial for convenient reconstitution and use in multi‑factor in‑vitro experiments.
| Component | Mass per Vial (approx.) |
| BPC-157 | 10 mg |
| TB-500 (Thymosin Beta-4 Fragment) | 10 mg |
| Total Peptide Mass | 20 mg |
| Parameter | Specification |
| Molar Ratio | 1:1 |
| Purity (each component) | ≥99% (by HPLC) |
- In‑vitro studies investigating potential synergistic effects of BPC-157 and TB-500 on cellular regeneration and cytoskeletal dynamics.
- Research into actin polymerization, cell migration, and extracellular matrix remodeling.
- Cell culture supplementation (in‑vitro only) for combined peptide activity screening.
- Reference blend for analytical method development and comparative studies.
This product is sold strictly for laboratory research purposes only. It is not a drug, medicine, or medical device. Not for human or animal use, consumption, or administration. Not for diagnostic, therapeutic, or clinical applications. Not for use in food or cosmetics. By purchasing, you confirm that you are at least 21 years of age and affiliated with a qualified research institution or laboratory.
